INNOCARE(09969) - 2025 Q2 - Earnings Call Transcript

InnoCare Pharma (09969) Q2 2025 Earnings Call August 19, 2025 08:30 AM ET Speaker0Sure. Thank you so much, Ziyi, for the introduction. Good morning. Good evening, everyone. Thank you for participating Innocare Pharma twenty twenty five mid year earnings call.Innocare is a drug innovation company. Our mission is science drive innovation for the benefit of a patient worldwide. Our drug innovation focus on cancer and autoimmune diseases, the two therapeutic areas with a lot of unmet medical needs. And first of ...